Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009.

Aunes-Jansson M, Edvardsson N, Stridh M, Sörnmo L, Frison L, Berggren A.

J Electrocardiol. 2013 Jan-Feb;46(1):29-35. doi: 10.1016/j.jelectrocard.2012.09.002. Epub 2012 Dec 6.

PMID:
23219385
[PubMed - indexed for MEDLINE]
2.

Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation.

Aunes M, Egstrup K, Frison L, Berggren A, Stridh M, Sörnmo L, Edvardsson N.

J Electrocardiol. 2014 May-Jun;47(3):316-23. doi: 10.1016/j.jelectrocard.2013.12.008. Epub 2013 Dec 18.

PMID:
24508473
[PubMed - indexed for MEDLINE]
3.

Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.

Geller JC, Egstrup K, Kulakowski P, Rosenqvist M, Jansson MA, Berggren A, Edvardsson N, Sager P, Crijns HJ.

J Clin Pharmacol. 2009 Mar;49(3):312-22. doi: 10.1177/0091270008329549. Epub 2009 Jan 7.

PMID:
19129422
[PubMed - indexed for MEDLINE]
4.

Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.

Crijns HJ, Van Gelder IC, Walfridsson H, Kulakowski P, Rónaszéki A, Dedek V, Malm A, Almgren O.

Heart Rhythm. 2006 Nov;3(11):1321-31. Epub 2006 Jul 8.

PMID:
17074639
[PubMed - indexed for MEDLINE]
5.

Low atrial fibrillatory rate is associated with spontaneous conversion of recent-onset atrial fibrillation.

Choudhary MB, Holmqvist F, Carlson J, Nilsson HJ, Roijer A, Platonov PG.

Europace. 2013 Oct;15(10):1445-52. doi: 10.1093/europace/eut057. Epub 2013 Mar 20.

PMID:
23515337
[PubMed - indexed for MEDLINE]
Free Article
6.

Fibrillatory rate response to candesartan in persistent atrial fibrillation.

Bollmann A, Tveit A, Husser D, Stridh M, Sörnmo L, Smith P, Olsson SB.

Europace. 2008 Oct;10(10):1138-44. doi: 10.1093/europace/eun195. Epub 2008 Jul 28.

PMID:
18664477
[PubMed - indexed for MEDLINE]
Free Article
7.

Has the dream come through?

Di Biase L, Santangeli P, Burkhardt JD, Natale A.

J Electrocardiol. 2013 Jan-Feb;46(1):36-7. doi: 10.1016/j.jelectrocard.2012.11.003. No abstract available.

PMID:
23312359
[PubMed - indexed for MEDLINE]
8.

A genotype-dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation.

Husser D, Stridh M, Sörnmo L, Roden DM, Darbar D, Bollmann A.

Circ Arrhythm Electrophysiol. 2009 Feb;2(1):24-8. doi: 10.1161/CIRCEP.108.799098.

PMID:
19305639
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Validation and clinical application of time-frequency analysis of atrial fibrillation electrocardiograms.

Husser D, Stridh M, Cannom DS, Bhandari AK, Girsky MJ, Kang S, Sörnmo L, Bertil Olsson S, Bollmann A.

J Cardiovasc Electrophysiol. 2007 Jan;18(1):41-6.

PMID:
17229299
[PubMed - indexed for MEDLINE]
10.

Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG.

Bollmann A, Sonne K, Esperer HD, Toepffer I, Klein HU.

Ann Noninvasive Electrocardiol. 2002 Apr;7(2):92-7.

PMID:
12049679
[PubMed - indexed for MEDLINE]
11.

Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.

Goldstein RN, Khrestian C, Carlsson L, Waldo AL.

J Cardiovasc Electrophysiol. 2004 Dec;15(12):1444-50.

PMID:
15610294
[PubMed - indexed for MEDLINE]
12.

Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.

Corino VD, Holmqvist F, Mainardi LT, Platonov PG.

Europace. 2014 Apr;16(4):587-94. doi: 10.1093/europace/eut251. Epub 2013 Aug 29.

PMID:
23989533
[PubMed - indexed for MEDLINE]
13.
14.

Atrial fibrillatory rate and irregularity of ventricular response as predictors of clinical outcome in patients with atrial fibrillation.

Platonov PG, Holmqvist F.

J Electrocardiol. 2011 Nov-Dec;44(6):673-7. doi: 10.1016/j.jelectrocard.2011.07.024. Epub 2011 Sep 9.

PMID:
21907998
[PubMed - indexed for MEDLINE]
15.

Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion.

Bollmann A, Husser D, Steinert R, Stridh M, Soernmo L, Olsson SB, Polywka D, Molling J, Geller C, Klein HU.

J Cardiovasc Electrophysiol. 2003 Oct;14(10 Suppl):S162-5.

PMID:
14760919
[PubMed - indexed for MEDLINE]
16.

Ibutilide increases the variability and complexity of atrial fibrillation electrograms: antiarrhythmic insights using signal analyses.

Biviano AB, Ciaccio EJ, Gabelman T, Whang W, Garan H.

Pacing Clin Electrophysiol. 2013 Oct;36(10):1228-35. doi: 10.1111/pace.12224. Epub 2013 Jul 22.

PMID:
23875908
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Association between atrial fibrillatory rate and heart rate variability in patients with atrial fibrillation and congestive heart failure.

Corino VD, Cygankiewicz I, Mainardi LT, Stridh M, Vasquez R, Bayes de Luna A, Holmqvist F, Zareba W, Platonov PG.

Ann Noninvasive Electrocardiol. 2013 Jan;18(1):41-50. doi: 10.1111/anec.12019. Epub 2012 Nov 22.

PMID:
23347025
[PubMed - indexed for MEDLINE]
18.

Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.

Bollmann A, Binias KH, Toepffer I, Molling J, Geller C, Klein HU.

Am J Cardiol. 2002 Nov 1;90(9):1011-4. No abstract available.

PMID:
12398975
[PubMed - indexed for MEDLINE]
19.

Effect of mitral valve repair/replacement surgery on atrial arrhythmia behavior.

Raine D, Dark J, Bourke JP.

J Heart Valve Dis. 2004 Jul;13(4):615-21.

PMID:
15311868
[PubMed - indexed for MEDLINE]
20.

Atrial electrophysiological effects of ibutilide infusion in humans.

Schwartz RA, Langberg JJ.

Pacing Clin Electrophysiol. 2000 May;23(5):832-6.

PMID:
10833702
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk